Drugs / Kan Jang
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04847518 | May 2021 → Jan 2022 | COVID-19 | Swedish Herbal Institute AB | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kan Jang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04847518 ↗ |
| Known as | Kan Jang fixed combination | “Kan Jang fixed combination” NCT04847518 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “the herbal medicinal product Kan Jang®” NCT04847518 ↗ |